These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 24080988)

  • 1. Intracerebral hemorrhage after thrombolytic therapy in acute ischemic stroke patients with renal dysfunction.
    Chao TH; Lin TC; Shieh Y; Chang TY; Hung KL; Liu CH; Lee TH; Chang YJ; Lee JD; Chang CH
    Eur Neurol; 2013; 70(5-6):316-21. PubMed ID: 24080988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal impairment reduces the efficacy of thrombolytic therapy in acute ischemic stroke.
    Power A; Epstein D; Cohen D; Bathula R; Devine J; Kar A; Taube D; Duncan N; Ames D
    Cerebrovasc Dis; 2013; 35(1):45-52. PubMed ID: 23428996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.
    Kono S; Deguchi K; Morimoto N; Kurata T; Deguchi S; Yamashita T; Ikeda Y; Matsuura T; Narai H; Omori N; Manabe Y; Yunoki T; Takao Y; Kawata S; Kashihara K; Abe K
    J Stroke Cerebrovasc Dis; 2013 Apr; 22(3):190-6. PubMed ID: 21968092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Older age does not increase risk of hemorrhagic complications after intravenous and/or intra-arterial thrombolysis for acute stroke.
    Pundik S; McWilliams-Dunnigan L; Blackham KL; Kirchner HL; Sundararajan S; Sunshine JL; Tarr RW; Selman WR; Landis DM; Suarez JI
    J Stroke Cerebrovasc Dis; 2008 Sep; 17(5):266-72. PubMed ID: 18755405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of intracranial carotid artery calcification on the development of thrombolysis-induced intracerebral hemorrhage.
    Lin TC; Chao TH; Shieh Y; Lee TH; Chang YJ; Lee JD; Peng TI; Chang KC; Liou CW; Chang TY; Hung KL; Chang CH
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e455-62. PubMed ID: 23800497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-hospital outcomes with thrombolytic therapy in patients with renal dysfunction presenting with acute ischaemic stroke.
    Agrawal V; Rai B; Fellows J; McCullough PA
    Nephrol Dial Transplant; 2010 Apr; 25(4):1150-7. PubMed ID: 19945951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does dementia increase risk of thrombolysis?: a case-control study.
    Alshekhlee A; Li CC; Chuang SY; Vora N; Edgell RC; Kitchener JM; Kale SP; Feen E; Piriyawat P; Callison RC; Cruz-Flores S
    Neurology; 2011 May; 76(18):1575-80. PubMed ID: 21451151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is renal dysfunction associated with adverse stroke outcome after thrombolytic therapy?
    Hsieh CY; Lin HJ; Sung SF; Hsieh HC; Lai EC; Chen CH
    Cerebrovasc Dis; 2014; 37(1):51-6. PubMed ID: 24401854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of Renal Impairment on Outcome for Thrombolysis-Treated Acute Ischemic Stroke: ENCHANTED (Enhanced Control of Hypertension and Thrombolysis Stroke Study) Post Hoc Analysis.
    Carr SJ; Wang X; Olavarria VV; Lavados PM; Rodriguez JA; Kim JS; Lee TH; Lindley RI; Pontes-Neto OM; Ricci S; Sato S; Sharma VK; Woodward M; Chalmers J; Anderson CS; Robinson TG;
    Stroke; 2017 Sep; 48(9):2605-2609. PubMed ID: 28739832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrinogen decrease after intravenous thrombolysis in ischemic stroke patients is a risk factor for intracerebral hemorrhage.
    Vandelli L; Marietta M; Gambini M; Cavazzuti M; Trenti T; Cenci MA; Casoni F; Bigliardi G; Pentore R; Nichelli P; Zini A
    J Stroke Cerebrovasc Dis; 2015 Feb; 24(2):394-400. PubMed ID: 25497721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does renal dysfunction modify the effect of intravenous thrombolysis for acute ischemic stroke within 4.5 hours of onset? A multicenter observational study.
    Hsieh CY; Lin HJ; Sung SF; Yang YH; Lai EC; Hsieh HC; Chen CH
    J Stroke Cerebrovasc Dis; 2015 Mar; 24(3):673-9. PubMed ID: 25577428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.
    Wolfe T; Suarez JI; Tarr RW; Welter E; Landis D; Sunshine JL; Zaidat OO
    J Stroke Cerebrovasc Dis; 2008; 17(3):121-8. PubMed ID: 18436152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe renal impairment is associated with symptomatic intracerebral hemorrhage after thrombolysis for ischemic stroke.
    Tütüncü S; Ziegler AM; Scheitz JF; Slowinski T; Rocco A; Endres M; Nolte CH
    Stroke; 2013 Nov; 44(11):3217-9. PubMed ID: 24003042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of in-hospital mortality and the risk of symptomatic intracerebral hemorrhage after thrombolytic therapy with recombinant tissue plasminogen activator in acute ischemic stroke.
    Al-Khaled M; Matthis C; Eggers J
    J Stroke Cerebrovasc Dis; 2014 Jan; 23(1):7-11. PubMed ID: 22578915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood pressure variability after intravenous thrombolysis in acute stroke does not predict intracerebral hemorrhage but poor outcome.
    Kellert L; Sykora M; Gumbinger C; Herrmann O; Ringleb PA
    Cerebrovasc Dis; 2012; 33(2):135-40. PubMed ID: 22179586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there a decreased risk of intracerebral hemorrhage and mortality in obese patients treated with intravenous thrombolysis in acute ischemic stroke?
    Hassan AE; Chaudhry SA; Jani V; Grigoryan M; Khan AA; Adil MM; Qureshi AI
    J Stroke Cerebrovasc Dis; 2013 May; 22(4):545-9. PubMed ID: 23453555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The iScore predicts efficacy and risk of bleeding in the National Institute of Neurological disorders and Stroke Tissue Plasminogen Activator Stroke Trial.
    Saposnik G; Demchuk A; Tu JV; Johnston SC;
    J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):876-82. PubMed ID: 23102741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombolysis in experimental cerebral amyloid angiopathy and the risk of secondary intracerebral hemorrhage.
    Reuter B; Grudzenski S; Chatzikonstantinou E; Meairs S; Ebert A; Heiler P; Schad LR; Staufenbiel M; Hennerici MG; Fatar M
    Stroke; 2014 Aug; 45(8):2411-6. PubMed ID: 25005438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue plasminogen activator overdose in acute ischemic stroke patients linked to poorer functional outcomes.
    Sahlas DJ; Gould L; Swartz RH; Mohammed N; McNicoll-Whiteman R; Naufal F; Oczkowski W
    J Stroke Cerebrovasc Dis; 2014 Jan; 23(1):155-9. PubMed ID: 23375748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced estimated glomerular filtration rate is associated with stroke outcome after intravenous rt-PA: the Stroke Acute Management with Urgent Risk-Factor Assessment and Improvement (SAMURAI) rt-PA registry.
    Naganuma M; Koga M; Shiokawa Y; Nakagawara J; Furui E; Kimura K; Yamagami H; Okada Y; Hasegawa Y; Kario K; Okuda S; Nishiyama K; Minematsu K; Toyoda K
    Cerebrovasc Dis; 2011; 31(2):123-9. PubMed ID: 21088392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.